Tuesday, May 30, 2017 4:05:00 PM
We are certainly interested in doing studies in collaboration with Novartis on combination therapies but are not in the position to discuss that until the license is actually in place. And that won’t take place until the payment, the $7 million payment takes place sometime in middle of this year.
In addition, this part of that statement regarding collaboration on combo studies from the transcript:
"...but are not in the position to discuss that until the license is actually in place."
has me very interested and I suspect there will be more news about other projects released much quicker than most would anticipate.
Today, however, the question was why the trader lethargy today? And I still believe that my reasons were valid- your post regarding pending regulatory approval being a catalyst notwithstanding
Theo 
;-)
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
